|
1
|
Goo YA and Goodlett DR: Advances in
proteomic prostate cancer biomarker discovery. J Proteomics.
73:1839–1850. 2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Imafuku Y, Omenn GS and Hanash S:
Proteomics approaches to identify tumor antigen directed
autoantibodies as cancer biomarkers. Dis Markers. 20:149–153.
2004.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ho PTB, Clark IM and Le LTT:
MicroRNA-based diagnosis and therapy. Int J Mol Sci.
23(7167)2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kramer J, Harcos P, Prohászka Z, Horváth
L, Karádi I, Singh M, Császár A, Romics L and Füst G: Frequencies
of certain complement protein alleles and serum levels of
anti-heat-shock protein antibodies in cerebrovascular diseases.
Stroke. 31:2648–2652. 2000.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Machida T, Kubota M, Kobayashi E, Iwadate
Y, Saeki N, Yamaura A, Nomura F, Takiguchi M and Hiwasa T:
Identification of stroke-associated-antigens via screening of
recombinant proteins from the human expression cDNA library
(SEREX). J Translat Med. 13(71)2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yoshida Y, Wang H, Hiwasa T, Machida T,
Kobayashi E, Mine S, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H,
et al: Elevation of autoantibody level against PDCD11 in patients
with transient ischemic attack. Oncotarget. 9:8836–8848.
2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wang H, Zhang XM, Tomiyoshi G, Nakamura R,
Shinmen N, Kuroda H, Kimura R, Mine S, Kamitsukasa I, Wada T, et
al: Association of serum levels of antibodies against MMP1, CBX1,
and CBX5 with transient ischemic attack and cerebral infarction.
Oncotarget. 9:5600–5613. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yoshida Y, Zhang XM, Wang H, Machida T,
Mine S, Kobayashi E, Adachi A, Matsutani T, Kamitsukasa I, Wada T,
et al: Elevated levels of autoantibodies against DNAJC2 in sera of
patients with atherosclerotic diseases. Heliyon.
6(e04661)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li SY, Yoshida Y, Kobayashi E, Kubota M,
Matsutani T, Mine S, Machida T, Maezawa Y, Takemoto M, Yokote K, et
al: Serum anti-AP3D1 antibodies are risk factors for acute ischemic
stroke related with atherosclerosis. Sci Rep.
11(13450)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kubota M, Yoshida Y, Kobayashi E,
Matsutani T, Li SY, Zhang BS, Mine S, Machida T, Takizawa H, Hiwasa
T and Iwadate Y: Serum anti-SERPINE1 antibody as a potential
biomarker of acute cerebral infarction. Sci Rep.
11(21772)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hiwasa T, Wang H, Goto KI, Mine S, Machida
T, Kobayashi E, Yoshida Y, Adachi A, Matsutani T, Sata M, et al:
Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as
predictive risk markers for acute ischemic stroke. BMC Med.
19(131)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kubota M, Zhang BS, Li SY, Yoshida Y, Wang
H, Adachi A, Matsutani T, Mine S, Machida T, Kamitsukasa I, et al:
Serum anti-TSTD2 antibody as a biomarker for
atherosclerosis-induced ischemic stroke and chronic kidney disease.
Med Int (Lond). 3(4)2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hiwasa T, Machida T, Zhang XM, Kimura R,
Wang H, Iwase K, Ashino H, Taira A, Arita E, Mine S, et al:
Elevated levels of autoantibodies against ATP2B4 and BMP-1 in sera
of patients with atherosclerosis-related diseases. Immunome Res.
11(097)2015.
|
|
14
|
Nakamura R, Tomiyoshi G, Shinmen N, Kuroda
H, Kudo T, Doi H, Mine S, Machida T, Kamitsukasa I, Wada T, et al:
An anti-deoxyhypusine synthase antibody as a marker of
atherosclerosis-related cerebral infarction, myocardial infarction,
diabetes mellitus, and chronic kidney disease. SM Atheroscler J.
1(1001)2017.
|
|
15
|
Hiwasa T, Tomiyoshi G, Nakamura R, Shinmen
N, Kuroda H, Kunimatsu M, Mine S, Machida T, Sato E, Takemoto M, et
al: Serum SH3BP5-specific antibody level is a biomarker of
atherosclerosis. Immunome Res. 13(132)2017.
|
|
16
|
Zhang XM, Wang H, Mine S, Takemoto M,
Yokote K, Kitamura K, Kobayashi Y, Machida T, Kobayashi E, Yoshida
Y, et al: Association of serum anti-prolylcarboxypeptidase antibody
marker with atherosclerotic diseases accompanied by hypertension. J
Mol Biomark Diagn. 8(361)2017.
|
|
17
|
Sumazaki M, Shimada H, Ito M, Shiratori F,
Kobayashi E, Yoshida Y, Adachi A, Matsutani T, Iwadate Y, Mine S,
et al: Serum anti-LRPAP1 is a common biomarker for digestive organ
cancers and atherosclerotic diseases. Cancer Sci. 111:4453–4464.
2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li SY, Yoshida Y, Kobayashi E, Adachi A,
Hirono S, Matsutani T, Mine S, Machida T, Ohno M, Nishi E, et al:
Association between serum anti-ASXL2 antibody levels and acute
ischemic stroke, acute myocardial infarction, diabetes mellitus,
chronic kidney disease and digestive organ cancer, and their
possible association with atherosclerosis and hypertension. Int J
Mol Med. 46:1274–1288. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chen PM, Ohno M, Hiwasa T, Nishi K, Saijo
S, Sakamoto J, Morita Y, Matsuda S, Watanabe S, Kuwabara Y, et al:
Nardilysin is a promising biomarker for the early diagnosis of
acute coronary syndrome. Int J Cardiol. 243:1–8. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Palmer JP, Asplin CM, Clemons P, Lyen K,
Tatpati O, Raghu PK and Paquette TL: Insulin antibodies in
insulin-dependent diabetics before insulin treatment. Science.
222:1337–1339. 1983.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Baekkeskov S, Aanstoot HJ, Christgau S,
Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H and De
Camilli P: Identification of the 64K autoantigen in insulin
dependent diabetes as the GABA-synthesizing enzyme glutamic acid
decarboxylase. Nature. 347:151–156. 1990.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hiwasa T, Zhang XM, Kimura R, Ohno M, Chen
PM, Nishi E, Ono K, Kimura T, Kamitsukasa I, Wada T, et al:
Elevated adiponectin antibody levels in sera of patients with
atherosclerosis-related coronary artery disease, cerebral
infarction, and diabetes mellitus. J Circ Biomark.
5(8)2016.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Sugimoto K, Tomiyoshi G, Mori M, Kuwabara
S, Hirano S, Sawai S, Beppu M, Muto M, Uzawa A, Kitamura K, et al:
Identification of serum anti-GADD34 antibody as a common marker of
diabetes mellitus and parkinson disease. J Alzheimers Dis
Parkinsonism. 7(358)2017.
|
|
24
|
Tomiyoshi G, Nakamura R, Shinmen N,
Yoshida Y, Mine S, Machida T, Iwase K, Iwadate Y, Hiwasa T and
Kuroda H: GADD34 activates p53 and may have utility as a marker of
atherosclerosis. Front Med (Lausanne). 10(1128921)2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yamagata H, Hayashi A, Yoshida Y,
Koshizaka M, Onishi S, Yoshida T, Hiwasa T and Takemoto M:
Association of high proprotein convertase subtilisin/kexin type 9
antibody level with poor prognosis in patients with diabetes: A
prospective study. Sci Rep. 13(5391)2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Shimada H, Takeda A, Arima M, Okazumi S,
Matsubara H, Nabeya Y, Funami Y, Hayashi H, Gunji Y, Suzuki T, et
al: Serum p53 antibody is a useful tumor marker in superficial
esophageal squamous cell carcinoma. Cancer. 89:1677–1683.
2000.PubMed/NCBI
|
|
27
|
Shimada H, Ochiai T and Nomura F: Japan
p53 Antibody Research Group. Titration of serum p53 antibodies in
1,085 patients with various types of malignant tumors: A
multiinstitutional analysis by the Japan p53 antibody research
group. Cancer. 97:682–689. 2003.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Nakashima K, Shimada H, Ochiai T,
Kuboshima M, Kuroiwa N, Okazumi S, Matsubara H, Nomura F, Takiguchi
M and Hiwasa T: Serological identification of TROP2 by recombinant
cDNA expression cloning using sera of patients with esophageal
squamous cell carcinoma. Int J Cancer. 112:1029–1035.
2004.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kuboshima M, Shimada H, Liu TL, Nakashima
K, Nomura F, Takiguchi M, Hiwasa T and Ochiai T: Identification of
a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell
carcinoma. Int J Oncol. 28:463–468. 2006.PubMed/NCBI
|
|
30
|
Kuboshima M, Shimada H, Liu TL, Nomura F,
Takiguchi M, Hiwasa T and Ochiai T: Presence of serum tripartite
motif-containing 21 antibodies in patients with esophageal squamous
cell carcinoma. Cancer Sci. 97:380–386. 2006.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Shimada H, Kuboshima M, Shiratori T,
Nabeya Y, Takeuchi A, Takagi H, Nomura F, Takiguchi M, Ochiai T and
Hiwasa T: Serum anti-myomegalin antibodies in patients with
esophageal squamous cell carcinoma. Int J Oncol. 30:97–103.
2007.PubMed/NCBI
|
|
32
|
Shimada H, Shiratori T, Yasuraok M, Kagaya
A, Kuboshima M, Nomura F, Takiguchi M, Ochiai T, Matsubara H and
Hiwasa T: Identification of makorin 1 as a novel SEREX antigen of
esophageal squamous cell carcinoma. BMC Cancer.
9(232)2009.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kagaya A, Shimada H, Shiratori T,
Kuboshima M, Nakashima-Fujita K, Yasuraoka M, Nishimori T, Kurei S,
Hachiya T, Murakami A, et al: Identification of a novel SEREX
antigen family, ECSA, in esophageal squamous cell carcinoma.
Proteome Sci. 9(31)2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Shimada H, Ito M, Kagaya A, Shiratori T,
Kuboshima M, Suzuki M, Liu TL, Nabeya Y, Matsubara H, Matsushita K,
et al: Elevated serum antibody levels against cyclin L2 in patients
with esophageal squamous cell carcinoma. J Cancer Sci Ther.
7:60–66. 2015.
|
|
35
|
Ito M, Hiwasa T, Yajima S, Suzuki T,
Oshima Y, Nanami T, Sumazaki M, Shiratori F, Li SY, Iwadate Y, et
al: Low anti-CFL1 antibody with high anti-ACTB antibody is a poor
prognostic factor in esophageal squamous cell carcinoma. Esophagus.
19:617–625. 2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ito M, Yajima S, Suzuki T, Oshima Y,
Nanami T, Sumazaki M, Shiratori F, Wang H, Hu L, Takizawa H, et al:
The combination of positive anti-WDR1 antibodies with negative
anti-CFL1 antibodies is a poor prognostic factor for patients with
esophageal carcinoma. Med Int (Lond). 3(11)2023.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Kobayashi S, Hoshino T, Hiwasa T, Satoh M,
Rahmutulla B, Tsuchida S, Komukai Y, Tanaka T, Matsubara H, Shimada
H, et al: Anti-FIRs (PUF60) auto-antibodies are detected in the
sera of early-stage colon cancer patients. Oncotarget.
7:82493–82503. 2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kobayashi S, Hiwasa T, Ishige T,
Rahmutulla B, Kano M, Hoshino T, Minamoto T, Shimada H, Nomura F,
Matsubara H and Matsushita K: Anti-FIRΔexon2, a splicing variant
form of PUF60, auto-antibody is detected in the sera of esophageal
squamous cell carcinoma. Cancer Sci. 110:2004–2013. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Matsutani T, Hiwasa T, Takiguchi M, Oide
T, Kunimatsu M, Saeki N and Iwadate Y: Autologous antibody to
src-homology 3-domain GRB2-like 1 specifically increases in the
sera of patients with low-grade gliomas. J Exp Clin Cancer Res.
31(85)2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Adachi-Hayama M, Adachi A, Shinozaki N,
Matsutani T, Hiwasa T, Takiguchi M, Saeki N and Iwadate Y:
Circulating anti-filamin C antibody as a potential serum biomarker
for low-grade gliomas. BMC Cancer. 14(452)2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Hontani K, Tsuchikawa T, Hiwasa T,
Nakamura T, Ueno T, Kushibiki T, Takahashi M, Inoko K, Takano H,
Takeuchi S, et al: Identification of novel serum autoantibodies
against EID3 in non-functional pancreatic neuroendocrine tumors.
Oncotarget. 8:106206–106221. 2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Takahashi M, Tsuchikawa T, Hiwasa T,
Nakamura T, Hontani K, Kushibiki T, Inoko K, Takano H, Hatanaka Y,
Matsushita K, et al: Identification of antibody against
wingless-type MMTV integration site family member 7B as a biliary
cancer tumor marker. Oncol Rep. 49(34)2023.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Matsumura T, Terada J, Kinoshita T,
Sakurai Y, Yahaba M, Ema R, Amata A, Sakao S, Nagashima K, Tatsumi
K and Hiwasa T: Circulating anti-coatomer protein complex subunit
epsilon (COPE) autoantibodies as a potential biomarker for cardio-
and cerebro-vascular events in patients with obstructive sleep
apnea. J Clin Sleep Med. 13:393–400. 2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Matsumura T, Terada J, Kinoshita T,
Sakurai Y, Yahaba M, Tsushima K, Sakao S, Nagashima K, Iwata Y,
Ozaki T, et al: Autoantibody against NBL1 in obstructive sleep
apnea patients with cardiovascular disease. PLoS One.
13(e0195015)2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Katsumata Y, Terada J, Matsumura T,
Koshikawa K, Sakao S, Tomiyoshi G, Shinmen N, Nakamura R, Kuroda H,
Nagashima K, et al: Circulating anti-sorting nexins 16 antibodies
as an emerging biomarker of coronary artery disease in patients
with obstructive sleep apnea. Diagnostics (Basel).
10(71)2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Adams HP Jr, Bendixen BH, Kappelle LJ,
Biller J, Love BB, Gordon DL and Marsh EE III: Classification of
subtype of acute ischemic stroke. Definitions for use in a
multicenter clinical trial. TOAST. Trial of Org 10172 in acute
stroke treatment. Stroke. 24:35–41. 1993.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Nishiura R, Fujimoto S, Sato Y, Yamada K,
Hisanaga S, Hara S, Nakao H and Kitamura K: Elevated
osteoprotegerin levels predict cardiovascular events in new
hemodialysis patients. Am J Nephrol. 29:257–263. 2009.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Komatsu H, Fujimoto S, Hara S, Fukuda A,
Fukudome K, Yamada K, Sato Y and Kitamura K: Recent therapeutic
strategies improve renal outcome in patients with IgA nephropathy.
Am J Nephrol. 30:19–25. 2009.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Chumpolkulwong N, Sakamoto K, Hayashi A,
Iraha F, Shinya N, Matsuda N, Kiga D, Urushibata A, Shirouzu M, Oki
K, et al: Translation of ‘rare’ codons in a cell-free protein
synthesis system from escherichia coli. J Struct Funct Genomics.
7:31–36. 2006.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Tsugane S and Sawada N: The JPHC study:
Design and some findings on the typical Japanese diet. Jpn J Clin
Oncol. 44:777–782. 2014.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Ikeda A, Iso H, Sasazuki S, Inoue M and
Tsugane S: JPHC Study Group. The combination of Helicobacter
pylori- and cytotoxin-associated gene-A seropositivity in relation
to the risk of myocardial infarction in middle-aged Japanese: The
Japan public health center-based study. Atherosclerosis. 230:67–72.
2013.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Iso H, Noda H, Ikeda A, Yamagishi K, Inoue
M, Iwasaki M and Tsugane S: The impact of C-reactive protein on
risk of stroke, stroke subtypes, and ischemic heart disease in
middle-aged Japanese: The Japan public health center-based study. J
Atheroscler Thromb. 19:756–766. 2012.PubMed/NCBI
|
|
53
|
Camp RL, Dolled-Filhart M and Rimm DL:
X-tile: A new bio-informatics tool for biomarker assessment and
outcome-based cut-point optimization. Clin Cancer Res.
10:7252–7259. 2004.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Lauriat TL, Dracheva S, Kremerskothen J,
Duning K, Haroutunian V, Buxbaum JD, Hyde TM, Kleinman JE and
McInnes LA: Characterization of KIAA0513, a novel signaling
molecule that interacts with modulators of neuroplasticity,
apoptosis, and the cytoskeleton. Brain Res. 1121:1–11.
2006.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Tran LT, Park HJ and Kim HD: Is the
carotid intima-media thickness really a good surrogate marker of
atherosclerosis? J Atheroscler Thromb. 19:680–690. 2012.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Zureik M, Ducimetière P, Touboul PJ,
Courbon D, Bonithon-Kopp C, Berr C and Magne C: Common carotid
intima-media thickness predicts occurrence of carotid
atherosclerotic plaques: Longitudinal results from the aging
vascular study (EVA) study. Arterioscler Thromb Vasc Biol.
20:1622–1629. 2000.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Shirai K, Utino J, Otsuka K and Takata M:
A novel blood pressure-independent arterial wall stiffness
parameter; cardio-ankle vascular index (CAVI). J Atheroscler
Thromb. 13:101–107. 2006.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Floras JS: Hypertension and sleep apnea.
Can J Cardiol. 31:889–897. 2015.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Gallagher EJ and LeRoith D: Obesity and
diabetes: The increased risk of cancer and cancer-related
mortality. Physiol Rev. 95:727–748. 2015.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Goto A, Yamaji T, Sawada N, Momozawa Y,
Kamatani Y, Kubo M, Shimazu T, Inoue M, Noda M, Tsugane S and
Iwasaki M: Diabetes and cancer risk: A mendelian randomization
study. Int J Cancer. 146:712–719. 2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Tapia-Vieyra JV, Delgado-Coello B and
Mas-Oliva J: Atherosclerosis and cancer; A resemblance with
far-reaching implications. Arch Med Res. 48:12–26. 2017.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Makrilia N, Lappa T, Xyla V, Nikolaidis I
and Syrigos K: The role of angiogenesis in solid tumours: An
overview. Eur J Intern Med. 20:663–671. 2009.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Jarvandi S, Davidson NO and Schootman M:
Increased risk of colorectal cancer in type 2 diabetes is
independent of diet quality. PLoS One. 8(e74616)2013.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Fujihara S, Kato K, Morishita A, Iwama H,
Nishioka T, Chiyo T, Nishiyama N, Miyoshi H, Kobayashi M, Kobara H,
et al: Antidiabetic drug metformin inhibits esophageal
adenocarcinoma cell proliferation in vitro and in
vivo. Int J Oncol. 46:2172–2180. 2015.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Berger NA: Young adult cancer: Influence
of the obesity pandemic. Obesity (Silver Spring). 26:641–650.
2018.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Hiwasa T and Shimada H: Autoantibody in
cancer. In: Biomarkers in Cancer Therapy. Shimada H (ed). Springer
Nature, Singapore, 25-40, 2018.
|
|
67
|
Zhou Y, Yang Q, Chi J, Dong B, Lv W, Shen
L and Wang Y: Comorbidities and the risk of severe or fatal
outcomes associated with coronavirus disease 2019: A systematic
review and meta-analysis. Int J Infect Dis. 99:47–56.
2020.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Wu T, Zuo Z, Kang S, Jiang L, Luo X, Xia
Z, Liu J, Xiao X, Ye M and Deng M: Multi-organ dysfunction in
patients with COVID-19: A systematic review and meta-analysis.
Aging Dis. 11:874–894. 2020.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Ye Q, Lu D, Shang S, Fu J, Gong F, Shu Q
and Mao J: Crosstalk between coronavirus disease 2019 and
cardiovascular disease and its treatment. ESC Heart Fail.
7:3464–3472. 2020.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Maas MB, Kim M, Malkani RG, Abbott SM and
Zee PC: Obstructive sleep apnea and risk of COVID-19 infection,
hospitalization and respiratory failure. Sleep Breath.
25:1155–1157. 2021.PubMed/NCBI View Article : Google Scholar
|
